AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5145.56M
Enterprise Value 383.2M
Trailing P/E N/A
Forward P/E 1-0.96
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.59
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.67

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-56.01%
Return on Equity (ttm)-202.46%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -124.57M
Net Income Avi to Common (ttm)-129.06M
Diluted EPS (ttm)-8.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)107M
Total Cash Per Share (mrq)4.7
Total Debt (mrq)44.18M
Total Debt/Equity (mrq)78.59
Current Ratio (mrq)2.63
Book Value Per Share (mrq)2.47

Cash Flow Statement

Operating Cash Flow (ttm)-134.21M
Levered Free Cash Flow (ttm)-80.21M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.09
52-Week Change 3-65.46%
S&P500 52-Week Change 38.16%
52 Week High 324.32
52 Week Low 33.81
50-Day Moving Average 36.73
200-Day Moving Average 38.85

Share Statistics

Avg Vol (3 month) 3605.22k
Avg Vol (10 day) 33.69M
Shares Outstanding 522.78M
Float 9.38M
% Held by Insiders 158.22%
% Held by Institutions 117.40%
Shares Short (May 31, 2019) 41.07M
Short Ratio (May 31, 2019) 44.32
Short % of Float (May 31, 2019) 411.36%
Short % of Shares Outstanding (May 31, 2019) 44.70%
Shares Short (prior month Apr 30, 2019) 41.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 8, 2019